Sepsis ImmunoScore vs ContaCT
AI Verdict
Choose Sepsis ImmunoScore if…
Choose Sepsis ImmunoScore if your primary goal is to leverage the first FDA-authorized AI diagnostic for rapid and precise sepsis risk assessment and prediction of patient deterioration. This tool is ideal for acute care settings needing to identify patients at high risk of adverse outcomes within 24 hours, enabling proactive and data-driven treatment decisions based on 22 EHR parameters.
View Sepsis ImmunoScore →Choose ContaCT if…
Choose ContaCT if your organization requires an AI-powered platform to accelerate the detection and streamline care coordination for specific acute conditions like stroke, pulmonary embolism, or cardiac issues. This solution is best suited for improving communication and workflow efficiency among specialists, ensuring timely treatment through real-time alerts, mobile image viewing, and secure messaging across your care teams.
View ContaCT →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Sepsis ImmunoScore | ContaCT |
|---|---|---|
| Pricing | Enterprise subscription model | Subscription-based |
| Deployment | Integrated into hospital EHR/EMR systems | Cloud-based, integrates with existing hospital IT infrastructure (PACS, EHR). |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ContaCTTool B (ContaCT) offers a more comprehensive and flexible user experience, including a mobile application for specialists to view images and communicate, real-time AI-powered alerts, and a high-fidelity 3D web and mobile image viewer. While Tool A (Sepsis ImmunoScore) emphasizes an intuitive and transparent display integrated into EHRs, Tool B's broader feature set facilitates more dynamic care coordination and specialist engagement across various devices.
Clinical Value
Sepsis ImmunoScoreBoth tools offer significant clinical value. However, Tool A (Sepsis ImmunoScore) stands out as the first FDA-authorized AI diagnostic for sepsis, providing both rapid diagnosis and prediction of critical adverse outcomes like mortality and ICU admission within 24 hours. This represents a groundbreaking advancement in managing a highly complex and fatal condition, with studies demonstrating high accuracy and potential to reduce antibiotic overprescription.
Pricing & Value
ContaCTBoth tools employ a non-transparent, variable subscription pricing model. However, Tool B (Viz LVO, formerly ContaCT) has received a New Technology Add-on Payment (NTAP) renewal from CMS, making it eligible for reimbursement up to $1,040 per eligible patient. This provides a clear and tangible financial benefit for adopting hospitals, indicating recognized economic value by a major payer that is not evident for Tool A.
Enterprise Readiness
ContaCTBoth tools demonstrate strong enterprise readiness with HIPAA compliance, BAA, and FDA clearances, and integrate with hospital systems. However, Tool B (ContaCT) has a significantly larger deployment footprint, serving nearly 2,000 hospitals globally, and explicitly mentions cloud-based deployment and integration with PACS in addition to EHRs. Its consistent SOC 2 Type II + HIPAA audit compliance further underscores its robust enterprise capabilities.
Innovation
Sepsis ImmunoScoreBoth are highly innovative, but Tool A (Sepsis ImmunoScore) holds a distinct edge as the 'first-ever FDA-authorized AI diagnostic for sepsis,' a significant breakthrough achieved through the rigorous De Novo regulatory pathway. This singular 'first-in-class' status for a complex and high-mortality condition represents a foundational innovation in its specific domain.
Support & Docs
ContaCTTool B (ContaCT) provides extensive and detailed support options, including 24/7 urgent phone support with a guaranteed 15-minute response time, email support, a comprehensive Help Center, customer resources, user guides, and a training academy. Tool A (Sepsis ImmunoScore) mentions training and a user manual but lacks specific details on ongoing customer support channels and response times.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Sepsis ImmunoScore | ContaCT |
|---|---|---|
| Tool Name | Sepsis ImmunoScore | ContaCT |
| Company | Prenosis | Viz.AI |
| Description | Sepsis ImmunoScore by Prenosis is the first FDA-authorized AI diagnostic for sepsis, providing rapid risk assessment and prediction of adverse outcomes. It analyzes 22 parameters from EHRs to generate a risk score and four risk categories, aiding clinicians in faster treatment decisions and improved patient outcomes. | Viz.ai is a pioneering AI-powered care coordination platform that accelerates disease detection and streamlines clinical workflows. With multiple FDA clearances, including the initial Viz.AI Contact application for stroke, it helps ensure patients receive timely treatment across over 1,700 hospitals globally. |
| Primary Use Case | Rapid risk assessment and prediction of adverse outcomes for sepsis | Accelerates disease detection and streamlines clinical workflows, particularly for stroke |
| Key Features | First FDA-authorized AI diagnostic for sepsis, AI/ML Software as a Medical Device (SaMD), Guides rapid diagnosis and prediction of sepsis, Leverages 22 diverse parameters (biomarkers and clinical data), Outputs a risk score and four discrete risk categories, Predicts risk of deterioration (length of stay, in-hospital mortality, ICU admission, mechanical ventilation, vasopressor use) within 24 hours, Integrated directly into hospital Electronic Medical Records (EMR/EHR), Intuitive display explains how parameters contribute to the score (transparency) | AI-powered disease detection (LVO, ICH, HCM, PE, Aneurysm), Real-time AI-powered alerts and notifications, Mobile application for specialists to view images and communicate, Secure, HIPAA-compliant group communication messaging, Integration with PACS and EHR systems, High-fidelity 3D web and mobile image viewer, Automated chart summarization, Guideline-based recommendations |
| Specialties | Critical Care, Emergency Medicine, Hospital Medicine | Emergency Medicine, Neurology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Sepsis ImmunoScore and ContaCT.
Frequently Asked Questions
More Comparisons
More matchups featuring Sepsis ImmunoScore or ContaCT
Backers
Who funded each tool's parent company.